Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
39 Other agents affecting metabolism
396 Antidiabetic agents
3969 Others
D09780 Anagliptin (JAN/INN)
Drug groups [BR:br08330]
Antidiabetic agent
DG02044 Hypoglycemic agent
DG01601 DPP-4 inhibitor
D09780 Anagliptin
Drug classes [BR:br08332]
Antidiabetic agent
DG01601 DPP-4 inhibitor
D09780 Anagliptin
DG02044 Hypoglycemic agent
D09780 Anagliptin
Target-based classification of drugs [BR:br08310]
Peptidases and inhibitors
Serine peptidases
Prolyl oligopeptidase family
DPP4 (CD26)
D09780 Anagliptin (JAN/INN) <JP>
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D09780
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D09780